News Report | January 16, 2024
Lilly Launches Digital Platform For Chronic Disease Management
On January 4, 2024, pharmaceutical company Eli Lilly and Company (Lilly) launched LillyDirect, a digital chronic disease management platform for consumers living with obesity, migraines, and diabetes. LillyDirect offers disease management resources, including access to independent health care professionals, tailored support, and direct home delivery of select Lilly medicines through third-party pharmacy dispensing services.
LillyDirect includes the following components:
- LillyDirect Pharmacy Solutions, a digital pharmacy for Lilly prescribed medications. LillyDirect works with accredited pharmacy-service provider organizations. Consumers who qualify can access Lilly’s financial assistance programs and savings card opportunities to reduce . . .